Portola Pharmaceuticals, Inc. Inventory Write-down
Portola Pharmaceuticals, Inc. reported Inventory Write-down of $2.11 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2020-05-11
- Portola Pharmaceuticals, Inc. inventory write-down for the quarter ending 2020-03-31 was $2.11M, a 46.51% decline year-over-year.
- Portola Pharmaceuticals, Inc. inventory write-down for the quarter ending 2019-12-31 was $21.00K.
- Portola Pharmaceuticals, Inc. inventory write-down for the quarter ending 2019-09-30 was $311.00K.
- Portola Pharmaceuticals, Inc. inventory write-down for the quarter ending 2019-06-30 was -$125.00K.
- Portola Pharmaceuticals, Inc. inventory write-down for fiscal 2019 was $4.15M, a 84.86% increase from fiscal 2018.
- Portola Pharmaceuticals, Inc. inventory write-down for fiscal 2018 was $2.25M.
- Portola Pharmaceuticals, Inc. inventory write-down for fiscal 2017 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2020-03-31 | $2.11M 10-Q · filed 2020-05-11 | $2.13M derived: sum of 2 quarters · filed 2020-05-11 | $2.44M derived: sum of 3 quarters · filed 2020-05-11 | $2.32M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $332.00K derived: sum of 2 quarters · filed 2020-02-28 | $207.00K derived: sum of 3 quarters · filed 2020-02-28 | $4.15M 10-K · filed 2020-02-28 |
| 2019-09-30 | $311.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $186.00K derived: sum of 2 quarters · filed 2019-11-05 | $4.13M 10-Q · filed 2019-11-05 | $4.13M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $3.82M 10-Q · filed 2019-08-07 | $3.82M derived: sum of 3 quarters · filed 2020-05-11 | |
| 2019-03-31 | $3.94M 10-Q · filed 2020-05-11 | $3.94M derived: sum of 2 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.25M 10-K · filed 2020-02-28 | ||
| 2018-09-30 | $2.25M 10-Q · filed 2019-11-05 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 |